Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases

Liu, Ying; Vu, Vivian; Sweeney, Gary

doi:10.3389/fendo.2019.00842

Cited by 58 publications

(41 citation statements)

References 222 publications

(252 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cardiometabolic diseases encompass a set of dysfunctions affecting the cardiovascular system. These are not limited to hard cardiovascular events such as coronary heart disease, myocardial infarction, and stroke, but also include cardiovascular risk factors, namely obesity, insulin resistance, endothelial dysfunction, atherosclerosis, lipid profile, or non-alcoholic fatty liver disease, among others [134].…”

Section: Effect Of Phytoestrogen Intake On Cardiometabolic Risk-relatmentioning

confidence: 99%

Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review

et al. 2020

View full text Add to dashboard Cite

Dietary phytoestrogens are bioactive compounds with estrogenic activity. With the growing popularity of plant-based diets, the intake of phytoestrogen-rich legumes (especially soy) and legume-derived foods has increased. Evidence from preclinical studies suggests these compounds may have an effect on hormones and health, although the results of human trials are unclear. The effects of dietary phytoestrogens depend on the exposure (phytoestrogen type, matrix, concentration, and bioavailability), ethnicity, hormone levels (related to age, sex, and physiological condition), and health status of the consumer. In this review, we have summarized the results of human studies on dietary phytoestrogens with the aim of assessing the possible hormone-dependent outcomes and health effects of their consumption throughout a lifespan, focusing on pregnancy, childhood, adulthood, and the premenopausal and postmenopausal stages. In pregnant women, an improvement of insulin metabolism has been reported in only one study. Sex hormone alterations have been found in the late stages of childhood, and goitrogenic effects in children with hypothyroidism. In premenopausal and postmenopausal women, the reported impacts on hormones are inconsistent, although beneficial goitrogenic effects and improved glycemic control and cardiovascular risk markers have been described in postmenopausal individuals. In adult men, different authors report goitrogenic effects and a reduction of insulin in non-alcoholic fatty liver patients. Further carefully designed studies are warranted to better elucidate the impact of phytoestrogen consumption on the endocrine system at different life stages.

show abstract

Section: Effect Of Phytoestrogen Intake On Cardiometabolic Risk-relatmentioning

confidence: 99%

Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Several short peptides and small molecules have been identified today to target AdipoRs and mimic some of ApN effects. These receptor agonists can induce similar downstream signaling cascades to ApN, such as AMPK, p38MAPK, and PPARα [120] (Table 1).…”

Section: Adiponectin Mimicsmentioning

confidence: 99%

“…Additional AdipoR activating peptides have also been identified in silico [120]. Pep70 is a potential AdipoR1 agonist and could significantly inhibit the proliferation of cells and suppress the expression of collagen type I alpha1 and TGF-β1, thus protecting against fibrotic responses [133].…”

Section: Peptides and Proteinsmentioning

confidence: 99%

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?

Abou‐Samra

Selvais

Dubuisson

et al. 2020

IJMS

View full text Add to dashboard Cite

Adiponectin (ApN) is a hormone abundantly secreted by adipocytes and it is known to be tightly linked to the metabolic syndrome. It promotes insulin-sensitizing, fat-burning, and anti-atherosclerotic actions, thereby effectively counteracting several metabolic disorders, including type 2 diabetes, obesity, and cardiovascular diseases. ApN is also known today to possess powerful anti-inflammatory/oxidative and pro-myogenic effects on skeletal muscles exposed to acute or chronic inflammation and injury, mainly through AdipoR1 (ApN specific muscle receptor) and AMP-activated protein kinase (AMPK) pathway, but also via T-cadherin. In this review, we will report all the beneficial and protective properties that ApN can exert, specifically on the skeletal muscle as a target tissue. We will highlight its effects and mechanisms of action, first in healthy skeletal muscle including exercised muscle, and second in diseased muscle from a variety of pathological conditions. In the end, we will go over some of AdipoRs agonists that can be easily produced and administered, and which can greatly mimic ApN. These interesting and newly identified molecules could pave the way towards future therapeutic approaches to potentially prevent or combat not only skeletal muscle disorders but also a plethora of other diseases with sterile inflammation or metabolic dysfunction.

show abstract

“…Действуя как селективный модулятор рецепторов PPARγ, телмисартан способен повышать концентрацию адипонектина в сыворотке крови -важнейшего медиатора из группы адипокинов, обладающего доказанным антидиабетическим, противовоспалительным и кардиопротективным действием [34].…”

Section: антигипертензивная эффективность телмисар танаunclassified

Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits

Sayutina

Butorova

Туаева

et al. 2020

Cardiovasc Ther Prev

View full text Add to dashboard Cite

Настоящая работа посвящена вопросам фармакологических особенностей и преимуществ использования антагониста рецепторов ангиотензина II телмисартана в реальной клинической практике. Данный бифункциональный представитель класса блокаторов рецепторов ангиотензина II первого типа обладает рядом уникальных фармакокинетических особенностей: наибольшей продолжительностью действия, высокой степенью липофильности и максимальной эффективностью в отношении активации рецепторов PPARγ. Представлены результаты многочисленных исследований, подтверждающих высокую эффективность телмисартана и способность контролировать артериальное давление в течение суток и ранние утренние часы по сравнению с другими антигипертензивными препаратами. Основные плеойтропные свойства телмисартана доказаны на большинстве этапов кардиоваскулярного и ренального континуумов, главными из которых являются снижение инсулинорезистентности, повышение уровня адипонектина, улучшение функциональной активности эндотелия, ангио и ренопротективные эффекты и способность обеспечивать регресс гипертрофии миокарда левого желудочка. Доказана способность телмисартана влиять на прогноз у пациентов высокого сердечно-сосудистого риска и обеспечивать снижение летальности и количества сердечно-сосудистых осложнений. Опираясь на результаты масштабных исследований, рассмотрены возможности использования телмисартана 80 мг/сут., в т. ч. в сочетании с гидрохлоротиазидом, как наиболее мощной двойной фиксированной комбинации и одной из основных современных стратегий антигипертензивной терапии. Ключевые слова: артериальная гипертензия, высокий сердечнососудистый риск, комбинированная антигипертензивная терапия, фиксированные комбинации, поражение органов-мишеней, блокаторы РААС, телмисартан, тиазидные диуретики. Отношения и деятельность: нет.

show abstract

Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases

Cited by 58 publications

References 222 publications

Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review

Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?

Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits

Contact Info

Product

Resources

About